Page last updated: 2024-11-07

n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(4-carboxycyclohexylmethyl)maleimide N-hydroxysuccinimide ester: used in the preparation of rabbit Fab'-peroxidase conjugates [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate : An N-hydroxysuccinimide ester derived from 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID125175
CHEBI ID63174
SCHEMBL ID45664
SCHEMBL ID181744
MeSH IDM0084457

Synonyms (78)

Synonym
64987-85-5
nsc344483
nsc-344483
smcc
4-(n-maleimidomethyl)cyclohexanecarboxylic acid n-hydroxysuccinimide ester, >=98%, powder
n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester
(2,5-dioxopyrrolidin-1-yl) 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylate
n-succinimidyl 4-(maleimidomethyl)cyclohexane-1-carboxylate
A8849
n-succinimidyl 4-(n-maleimidomethyl)cyclohexane-1-carboxylate;2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarboxylate
4-(n-maleimidomethyl)cyclohexanecarboxylic acid n-succinimidyl ester
n-succinimidyl 4-(n-maleimidomethyl)cyclohexanecarboxylate
trans-4-(maleimidomethyl)cyclohexanecarboxylic acid-nhs
4-(maleimidomethyl)cyclohexanecarboxylic acid-nhs
n-succinimidyl 4-(n-maleimidomethyl)cyclohexane-1-carboxylate
c16h18n2o6
AKOS016014151
2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarboxylate
unii-b357p1g1if
n-smc-carboxylate
n-hydroxysuccinimidyl 4-(n-maleimidomethylcyclohexane)-1-carboxylate
1h-pyrrole-2,5-dione, 1-((4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)cyclohexyl)methyl)-
nsc 344483
n-succinimidyl-4-(n-maleimidomethyl)cyclohexane-1-carboxylic acid
b357p1g1if ,
BP-20230
BP-20408
71875-81-5
FT-0604024
FT-0604078
succinimidyl 4-(n-maleimidomethyl)cyclohexane-1-carboxylate
CHEBI:63174
1-[(4-{[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}cyclohexyl)methyl]-1h-pyrrole-2,5-dione
AM84931
2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexane-1-carboxylate
AKOS015900701
2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cy clohexanecarboxylate
succinimidyl-4-(n-maleimidomethyl)cyclohexane-1-carboxylate
cyclohexanecarboxylic acid, 4-((2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)methyl)-, 2,5-dioxo-1-pyrrolidinyl ester
SCHEMBL45664
SCHEMBL181744
mfcd08274640
trans-n-succinimidyl 4-(maleimidomethyl)cyclohexane-1-carboxylate
2,5-dioxopyrrolidin-1-yl 4-[(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl]cyclohexanecarboxylate
JJAHTWIKCUJRDK-UHFFFAOYSA-N
trans-2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarboxylate
AC-28738
DTXSID30215307
mfcd00009634
4-(maleimidomethyl)cyclohexane-1-carboxylic acid n-hydroxysuccinimide ester
smcc;(2,5-dioxopyrrolidin-1-yl) 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylate;trans-2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarboxylate
J-507381
2,5-dioxopyrrolidin-1-yl (1r,4r)-4-[(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl]cyclohexane-1-carboxylate
AS-74774
BP-25107
CS-0058807
CS-B1513
2,5-dioxo-3-pyrrolidin-1-yl 4-[(2,5-dioxo-3-pyrrolin-1-yl)methyl]cyclohexanecarboxylate
succinimido 4-(n-maleimidomethyl)cyclohexanecarboxylate
HY-42360
SY019092
smcc crosslinker
succinimidyl trans-4-(maleimidylmethyl) cyclohexane-1-carboxylate
trans-2,5-dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexane-1-carboxylate
succinimidyl 4-(n-maleimidomethyl)cyclohexanecarboxylate
Q27132436
AS-11123
BCP10445
AMY21359
n-succinimidyl 4-(n-maleimidomethyl)cycl
D70437
Q27274295
mal-amchc-osu
WCA87581
n-succinimidyl 4-(n-maleimidomethyl)cyclohexanecarboxylate (2mg*5)
U0143
trans-4-(maleimidomethyl)cyclohexanecarboxylic acid-nhs ester
SY034493
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
maleimidesCompounds containing a cyclic dicarboximide skeleton in which the two carboacyl groups on nitrogen together with the nitrogen itself form a 1H-pyrrole-2,5-dione structure.
N-hydroxysuccinimide esterAn ester of N-hydroxysuccinimide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's6 (23.08)18.2507
2000's5 (19.23)29.6817
2010's11 (42.31)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.30 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]